Patents Assigned to MEC DYNAMICS CORPORATION
  • Publication number: 20120142114
    Abstract: The present invention provides apparatus and methods for performing assays for determining the time required for a sample of blood to coagulate. The apparatus comprises reaction chambers coated with one or more clotting agent. A drop of blood or equivalent is placed at the sample application port, diluted, and contacted with the clotting agents in the reaction chambers. The diluted blood sample can be moved back and forth through the reaction chambers until blood clots. The blood clotting process forms fibrin stands that prevent the flow of the blood sample in the reaction chambers. The clotting time is the total time from the sample entering the reaction chambers to the time at which the waveform in the reaction chambers change, or the motion or flow of the sample ceases, and can be measured by turbidity.
    Type: Application
    Filed: February 10, 2012
    Publication date: June 7, 2012
    Applicant: MEC DYNAMICS CORPORATION
    Inventors: Emmanuel C. Mpock, Wilma Mangan
  • Publication number: 20090117666
    Abstract: The present invention provides apparatus and methods for performing assays for determining the presence of and/or quantifying an analyte in a sample. The analyte and a label preferably immobilized on a particle are mixed to provide a homogenous solution. The homogeneous solution can be optionally made to flow through a filter. The homogenous solution or the filtrate can be metered through the read zone at a controlled flow rate and the presence of the label or the presence of the particle can be detected. The methods and apparatus of the invention do not require the use of a capture zone.
    Type: Application
    Filed: November 7, 2007
    Publication date: May 7, 2009
    Applicant: MEC Dynamics Corporation
    Inventors: Emmanuel Mpock, Wilma Mangan
  • Publication number: 20080318260
    Abstract: The present invention provides apparatus and methods for performing assays for determining the time required for a sample of blood to coagulate. The apparatus comprises reaction chambers coated with one or more clotting agent. A drop of blood or equivalent is placed at the sample application port, diluted, and contacted with the clotting agents in the reaction chambers. The diluted blood sample can be moved back and forth through the reaction chambers until blood clots. The blood clotting process forms fibrin stands that prevent the flow of the blood sample in the reaction chambers. The clotting time is the total time from the sample entering the reaction chambers to the time at which the waveform in the reaction chambers change, or the motion or flow of the sample ceases, and can be measured by turbidity.
    Type: Application
    Filed: June 20, 2008
    Publication date: December 25, 2008
    Applicant: MEC DYNAMICS CORPORATION
    Inventors: Emmanuel C. Mpock, Wilma Mangan